CN119604289A - 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物 - Google Patents

预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物 Download PDF

Info

Publication number
CN119604289A
CN119604289A CN202380056126.8A CN202380056126A CN119604289A CN 119604289 A CN119604289 A CN 119604289A CN 202380056126 A CN202380056126 A CN 202380056126A CN 119604289 A CN119604289 A CN 119604289A
Authority
CN
China
Prior art keywords
ergothioneine
composition
improving
salt
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380056126.8A
Other languages
English (en)
Chinese (zh)
Inventor
胜部谅
铃木寿荣
首藤刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of CN119604289A publication Critical patent/CN119604289A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380056126.8A 2022-08-17 2023-08-10 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物 Pending CN119604289A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-130122 2022-08-17
JP2022130122 2022-08-17
PCT/JP2023/029205 WO2024038821A1 (ja) 2022-08-17 2023-08-10 フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物

Publications (1)

Publication Number Publication Date
CN119604289A true CN119604289A (zh) 2025-03-11

Family

ID=89941602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380056126.8A Pending CN119604289A (zh) 2022-08-17 2023-08-10 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物

Country Status (4)

Country Link
JP (1) JPWO2024038821A1 (enrdf_load_stackoverflow)
CN (1) CN119604289A (enrdf_load_stackoverflow)
TW (1) TW202423421A (enrdf_load_stackoverflow)
WO (1) WO2024038821A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024172003A1 (ja) * 2023-02-16 2024-08-22 サントリーホールディングス株式会社 エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
WO2025063190A1 (ja) * 2023-09-19 2025-03-27 株式会社エル・エスコーポレーション エルゴチオネインを含有する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7681882B2 (ja) * 2019-10-03 2025-05-23 学校法人沖縄科学技術大学院大学学園 フレイルの判定方法
WO2022230487A1 (ja) * 2021-04-26 2022-11-03 サントリーホールディングス株式会社 赤血球及び／又はヘモグロビン増加用組成物

Also Published As

Publication number Publication date
JPWO2024038821A1 (enrdf_load_stackoverflow) 2024-02-22
TW202423421A (zh) 2024-06-16
WO2024038821A1 (ja) 2024-02-22

Similar Documents

Publication Publication Date Title
US20220211750A1 (en) Compositions and methods using a combination of calcium and at least one of oleuropein or metabolite thereof
CN119604289A (zh) 预防或改善衰弱用组合物，以及用于抑制或改善伴随年龄增长的身体活动能力下降的组合物
JP6641240B2 (ja) ナチュラルキラー細胞の活性化剤
WO2021230146A1 (ja) Ｎｒ及び／又はｎｍｎとセサミン類とを含有する組成物
CN117255683A (zh) 免疫细胞的代谢促进用组合物
CN117255628A (zh) 抗焦虑用组合物
JP2024069498A (ja) エルゴチオネイン又はその塩を含有する睡眠改善用組成物
TWI879956B (zh) 菸鹼醯胺腺嘌呤二核苷酸（ｎａｄ）濃度上升劑
TW202308613A (zh) 用於抑制腎功能降低或改善腎功能之組成物
WO2022230493A1 (ja) 白血球及び／又は好塩基球増加用組成物
WO2018207741A1 (ja) ＰＧＣ－１α生合成促進剤および遅筋速筋化抑制剤
WO2023090260A1 (ja) ヒスタミン－ｎ－メチルトランスフェラーゼ阻害用組成物
KR20240089543A (ko) 세사민류 및 에르고티오네인 또는 그 염을 함유하는 조성물
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
TWI888414B (zh) 生活活動量之維持、預防降低、抑制降低或改善用組成物之使用
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
WO2024203675A1 (ja) エルゴチオネイン又はその塩を含有する熱中症又は脱水症を予防、軽減又は改善するための組成物及び細胞内外水分を調節するための組成物
KR20250037719A (ko) 경구 조성물, 및 에르고티오네인에 유래하는 고미 및 글루코사민류 화합물에 유래하는 이미를 억제하는 방법
KR20250043432A (ko) 경구 조성물과, 에르고티오네인 또는 그의 염에서 유래하는 고미 및 젖 유래 세라마이드 함유 소재에서 유래하는 냄새를 억제하는 방법
CN120640988A (zh) 含有麦角硫因的血管扩张用组合物
TW202339725A (zh) 經口組成物及抑制源自麥角硫因之苦味之方法
TW202502321A (zh) 含有芝麻素類化合物及阿魏酸或其鹽之組成物
TW202342005A (zh) 經口組成物，及，抑制源自麥角硫因或其鹽之苦味及源自二十碳五烯酸類之臭味之方法
TW202342006A (zh) 經口組成物，及，抑制源自麥角硫因或其鹽之苦味及源自花生四烯酸類之臭味之方法
HK40075030A (en) Composition for sleep improvement comprising ergothioneine or salt thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination